Skip Navigation Bar
National Intitutes of Health
This finding aids platform will be replaced in Fall 2022. Please explore the new platform Beta soft release by visiting https://archivesspace.nlm.nih.gov

Robert M. Chanock Papers 1933-2008 (bulk 1950-2008)
search terms in context | full text File Size: 260 K bytes | Add this to my bookbag

Box | Folder Title
 
LID Lab Research Reports, 1960-2004 [subseries]:
33 14-27
Clinical research projects, 1960-1982
33 28
NIAID ad hoc contract review, 1973
33 29
Experimental immunoprophylaxis against respiratory syncytial virus infections in primates, undated
33 30
Experimental infection of primates with respiratory syncytial virus, undated
33 31
Histological and virological study of the neurovirulence in rhesus monkeys of a langat/dengue 4 chimeric virus and its parental strains langat virus and dengue type 4 virus, undated
33 32
Virological analyses of recombinant, live, attenuated respiratory syncytial virus subgroup A strain rA2cp248/404/1030ΔSH in healthy unscreened 4-12 weeks old infants, undated
33 33
RNA tumor viruses as etiologic agents of solid tumors as well as leukemia - NIAID/NCI collaborative research, 1968
33 34
Determination of the effect of an inducer of interferon (IN-CN) administered to upper respiratory tract on experimentally induced respiratory virus infections, 1969
33 35
Safety of cold adapted respiratory syncytial virus vaccine in infants 6-7 months of age, 1969
33 36
Serum complement in acute bronchiolitis, 1969
33 37
Pediatric adenovirus vaccine evaluations, 1971
33 38
Fort Detrick reports, 1972-1977
34 1
Chanock scientific studies, 1973-1992
34 2
Transferring viruses to NIAID, 1997-1998
34 3
Development of a rotavirus vaccine for the prevention of severe rotavirus diarrhea of infants and young children - LID Epidemiology section, c.2000
34 4-5
Development of new approaches for vaccines against the tick-borne encephalitis virus complex - Molecular Viral Biology section, 2000-2001
34 6
Phase I study of Ad4-ΔE3-HIVenv and Ad4-ΔE3-HIV/gag/pro recombinant vaccines in HIV-negative volunteers, 2001
34 7
Projected schedule for WNV/DEN4 chimera studies, 2001
34 8
New molecular approaches to develop live attenuated vaccines against the tick-borne encephalitis complex and the West Nile encephalitis virus, 2003
34 9
The development of vaccines for parainfluenza virus types 1, 2, and 3 - Respiratory Viruses section, 2004
34 10
In vitro models of paramyxovirus infection, 2004
34 11
New molecular approaches to develop live attenuated vaccines against tick-borne encephalitis virus complex and the West Nile and St. Louis encephalitis viruses - Respiratory Viruses section, 2004
34 12
NIAID 69-A - Study of non-bacterial respiratory disease A) children, 1966-1969
34 13
NIAID 69-B - Non-bacterial respiratory disease in military recruits - epidemiology and experimental immunoprophylaxis, 1966
34 14
NIAID 69-C - The etiology of acute respiratory disease in civilian adults, 1965
34 15
NIAID 69-D - Collaborative studies of biophysical properties of respiratory viruses which are important to the development of vaccines, 1966
34 16
NIAID 70-A - Laboratory studies of newly r4ecognized viruses associated with respiratory illness, 1966
34 17
NIAID 70-B - Characterization of newly discovered rhinovirus serotypes of human origin, 1966
34 18
NIAID 70-C - Basic studies on mycoplasma, 1966
34 19
NIAID 70-C.1 - Serology and seroepidemiology of mycoplasmas (pleuropneumonia-like organisms - PPLO), 1966
34 20
NIAID 70-D - Laboratory studies of viral hepatitis agents, 1966
34 21
NIAID 70-E - Biological and biophysical studies of rhinoviruses, 1966-1969
34 22
NIAID 72-B - Study of respiratory viruses and mycoplasmas in human volunteers, 1969